The Miami Entrepreneur

Dow Jones Newswires: 4D Pharma restates first-half earnings due to accounting change

Read Time:9 Second

The London- and U.S.-listed pharmaceutical company said the warrants and units should be recorded as derivative liabilities and not equity instruments under both IFRS and U.S. GAAP accounting standards.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Futures Movers: Stock futures reverse early losses after Biden, Putin agree ‘in principle’ to summit
Next post Dow Jones Newswires: Sharp Corp. shares fall sharply on plan to acquire display affiliate